7QM-15933-44378
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 118 / NY
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-25
- 2021-01-02
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-17
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-11
- 2021-07-12
-
2021-08-26
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-02
- 2021-10-07
- 2021-11-25
- 2022-02-24
-
2022-08-28
Survey response — 12 months, dose 3MedDRA: COVID-19, Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVID, pregnancy, childbirthMedDRA releases: 2024-11 · check-in free text available
-
2022-08-28
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-08-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 | |
| 2022-08-28 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: COVID, pregnancy, childbirth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release